US EditionThe Risk of Depression, Anxiety, and Suicidal Behavior in Patients with Obesity on Glucagon Like Peptide-1 Receptor Agonist Therapy
- Patients with obesity using GLP-1 receptor agonists like semaglutide and Mounjaro show reduced depression, anxiety, and suicidal behavior risks.
- Scientists believe these medications enhance mental health by lowering bodily inflammation and improving insulin functioning, factors associated with depression and cognitive deterioration.
- Multiple trials involving patients with and without mental illness demonstrated that GLP-1 therapies improve mood, emotional wellbeing, and reduce psychological distress.
- Dr. Breit emphasized that individuals with serious mental health conditions are at a significantly higher risk—approximately triple—of experiencing obesity, and highlighted the role of these medications in effectively managing this challenge.
- Experts note these weight-loss drugs have potential wide-ranging benefits and encourage updating clinical guidelines as further research unfolds.
13 Articles
13 Articles
The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy
This large community-based cohort study investigates the impact of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), specifically Liraglutide and Semaglutide, on the risk of developing psychiatric conditions such as depression, anxiety, and suicidal behaviors in patients with obesity. Utilizing post-marketing data, this research compares patients prescribed GLP-1 RAs (cases) with those not taking these medications (controls). The analysis s…
Medications to Lose Weight Quickly and Scalding Skin: the Solutions Are There but the Patient Must Be Informed.
Addome pendulo, turkey neck, curtain arms, emaciated face: the promise of slimming drugs is maintained, but without adequate medical control the physical aspect is affected. Certainly it is better to prevent, but however we come to meet the medicine and cosmetic surgery: it is spoken about in Rome until May 18, at the Congress of the Italian Society of Aesthetic Medicine (SIME). In the beginning it was the Ozempic, then wegovy, Mounjaro and othe…
Meghan Trainor Has Divided Fans After Changing A Lyric From Her Hit 'All About That Bass'
“I can only imagine how hard it would be for people who connected with her early in her career because she was body positive to see her succumb to Ozempic,” someone wrote of Trainor, who recently revealed that she used Mounjaro for weight loss.
Sydney Morning Herald
Weight-loss jabs could help tackle depression
Studies on more than 25,000 adults have found evidence that weight-loss medications such as Ozempic, Wegovy and Mounjaro could have a powerful impact on the mind as well as the body.
Coverage Details
Bias Distribution
- 57% of the sources lean Left
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
